American Delirium Society
2020 Year in Review Webinar

Avaiable Online to Public Until 2/12/21

Monday, November 16, 2020 at 3PM EST | Online

Program Co-Leads:

Mark A. Oldham, MD
University of Rochester Medical Center
Treasurer, American Delirium Society

Heidi L. Lindroth, PhD, RN
Mayo Clinic
Indiana University
Co-Chair of ADS Research Committee

Welcome

ADS would like to invite you to virtually attend our 11/16 meeting. We are excited about this offering and hope you will join us on 11/16/20 at 3pm EST as we present the top #delirium research from the 2019-2020 academic year. 

Presenters

Heidi L. Lindroth, PhD, RN
Mayo Clinic
Indiana University

Ben A. Palanca, MD, PhD, MSc
Washington University

Yasser Jamil, MD
Lebanese American University

References

  • Kimchi et al. Clinical EEG slowing correlates with delirium severity and predicts poor clinical outcomes. Neurology. 2019 Sep 24;93(13):e1260-71
  • Casey et al. Postoperative delirium is associated with increased plasma neurofilament light. Brain. 2020;143:47-54.
  • Khan et al. Biomarkers of delirium duration and delirium severity in the ICU. CCM; 2020;48(3):353-361
  • Brown et al. Effect of targeting mean arterial pressure during cardiopulmonary bypass by monitoring cerebral autoregulation on postsurgical delirium among older patients: A nested randomized controlled trial. JAMA Surg. 2019;154(9):819-26
  • Rosa et al. Effect of flexible family visitation on delirium among patients in the intensive care unit: The ICU Visits Randomized Clinical Trial. JAMA. 2019;322(3):216-28
  • Ford et al. The Healthy Heart-Mind Trial: Randomized Controlled Trial of Melatonin for Prevention of Delirium. JAGS. 2020 Jan;68(1):112-9
  • Wassenaar et al. External validation of two models to predict delirium in critically ill adults using either the confusion assessment method-ICU or the intensive care delirium screening checklist for delirium assessment. Crit Care Med. 2019 Oct;47(10):e827-35.
  • Rood et al. Prophylactic haloperidol effects on long-term quality of life in critically ill patients at high risk for delirium: Results of the REDUCE study. Anesthesiology. 2019 Aug;131:238-335.
  • Fong et al. The caregiver burden of delirium in older adults with Alzheimer disease and related disorders. JAGS. 2019 Dec;67(12):2587-92.

CE Credit

Description

The Year-in-Review highlights the most influential delirium research published between April 2, 2019 – April 1, 2020. These primary literature sources include 4 studies on biomarkers, 8 clinical trials, and 7 prevalence / outcome studies. The primary purpose of this module is to disseminate new knowledge gained through current research. Secondary purposes may include the facilitation of clinical advances through a change in clinician behaviors, improved collaboration among various disciplines and healthcare roles (i.e. established or early career researchers as well as acute, post-acute or community clinicians) and improved patient or population outcomes.

Physicians / Nurses / Pharmacists

In support of improving patient care, this activity has been planned and implemented by the American Delirium Society and Sutter Health. Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 

Satisfactory Completion 
Learners must complete a brief evaluation form to receive a certificate of completion. 

Credit Designation Statement – Sutter Health University designates this ENDURING MATERIAL activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM for physicians and 1.0 contact hours for nurses and 1.0 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.

Note to Pharmacists: This is not a valid statement of credit. Credit for pharmacists and technicians will be uploaded into CPE Monitor and will be available within 60 days post activity pending submission of individual EPID number and DOB (Mo/Day).

Note to Other Disciplines: AMA PRA Category 1 Credit™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Registered Nurses, & Respiratory Care Practitioners as long as the course is from an accredited organization and has been taken within the appropriate time frames. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements.

Learning Objectives - After Attending This Webinar You Should Be Able To

1. Articulate new knowledge identified in the most recent delirium research published within the last year.
2. Identify & implement best practices in delirium prevention, early intervention, and on-going post-delirium care.
3. Engage in improved collaboration with interprofessional members of the delirium healthcare team.
4. Support optimal patient & family outcomes with the inclusion of appropriate mitigation of emotional distress and the burden of care associated with delirium.

Disclosure of Conflict of Interest

No one involved in the planning or presentation of this activity has any relevant financial relationship with a commercial interest to disclose. – Provider Designee/Verification:  Kerri Maya, MSL, RN

Acknowledgement of Financial or In-Kind Commercial Support

No financial or in-kind commercial support was received for this educational activity.

Credit Claiming Instructions:

  1. Go to: https://ww2.highmarksce.com/sutterhealth/index.cfm?do=cnt.page&pg=1003&signInPurpose=credits
  2. Click the “Enter Claiming Code” button. Enter the claiming code for this session: 1278-YIR2020
  3. Learners must complete the session evaluation and attestation form to receive credit.
  4. Use the “View Transcript”, “View Certificate” or “Email Certificate” links to receive a copy for your records.

Questions? Email SHUCME@sutterhealth.org